Atai Life Sciences Management
Management criteria checks 2/4
Atai Life Sciences' CEO is Srini Rao, appointed in Jun 2024, has a tenure of less than a year. total yearly compensation is $1.73M, comprised of 31.7% salary and 68.3% bonuses, including company stock and options. directly owns 0.07% of the company’s shares, worth €138.00K. The average tenure of the management team and the board of directors is 0.8 years and 3.5 years respectively.
Key information
Srini Rao
Chief executive officer
US$1.7m
Total compensation
| CEO salary percentage | 31.7% |
| CEO tenure | less than a year |
| CEO ownership | 0.07% |
| Management average tenure | less than a year |
| Board average tenure | 3.5yrs |
Recent management updates
No updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -US$34m |
| Dec 31 2023 | US$2m | US$550k | -US$40m |
| Sep 30 2023 | n/a | n/a | -US$67m |
| Jun 30 2023 | n/a | n/a | -US$145m |
| Mar 31 2023 | n/a | n/a | -US$149m |
| Dec 31 2022 | US$4m | US$550k | -US$152m |
| Sep 30 2022 | n/a | n/a | -US$196m |
| Jun 30 2022 | n/a | n/a | -US$194m |
| Mar 31 2022 | n/a | n/a | -US$205m |
| Dec 31 2021 | US$12m | US$481k | -US$168m |
| Sep 30 2021 | n/a | n/a | -US$166m |
| Jun 30 2021 | n/a | n/a | -US$218m |
| Mar 31 2021 | n/a | n/a | -US$185m |
| Dec 31 2020 | US$3m | US$400k | -US$170m |
Compensation vs Market: Srini's total compensation ($USD1.73M) is above average for companies of similar size in the German market ($USD786.12K).
Compensation vs Earnings: Srini's compensation has been consistent with company performance over the past year.
CEO
Srini Rao (55 yo)
less than a year
Tenure
US$1,734,650
Compensation
Dr. Srinivas G. Rao, M.D., Ph D., also known as Srini, serves as Co-Chief Executive Officer of Atai Life Sciences N.V. since June 01, 2024. He serves as Clinical Advisory Board Member at Bionomics Limited...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder & Chairman of the Supervisory Board | no data | US$158.96k | 2.49% $ 4.9m | |
| Co-Founder & Co-CEO | less than a year | US$1.73m | 0.070% $ 138.2k | |
| Co-Founder | 6.1yrs | US$3.03m | 0.20% $ 391.5k | |
| Chief Financial Officer | less than a year | US$1.17m | 0.044% $ 87.0k | |
| Senior Vice President of Operations | less than a year | no data | no data | |
| Vice President of Investment & Venture Management | 3.5yrs | no data | no data | |
| Senior VP | 3.5yrs | no data | no data | |
| Senior Vice President of Early Development | less than a year | no data | no data | |
| Chief Business Officer | 1.7yrs | no data | 0.038% $ 75.9k | |
| Senior Vice President of Clinical Development | less than a year | no data | no data |
0.8yrs
Average Tenure
43yo
Average Age
Experienced Management: 9VC's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder & Chairman of the Supervisory Board | 3.5yrs | US$158.96k | 2.49% $ 4.9m | |
| Independent Member of Supervisory Board | 3.5yrs | US$151.96k | 0% $ 0 | |
| Independent Supervisory Director | less than a year | no data | no data | |
| Independent Member of Supervisory Board | 3.5yrs | US$140.46k | 0.0028% $ 5.5k | |
| Independent Supervisory Director | less than a year | no data | no data | |
| Independent Member of Supervisory Board | 3.5yrs | US$150.46k | 0.0028% $ 5.5k | |
| Independent Lead Member of Supervisory Board | 3.5yrs | US$158.96k | 0.31% $ 620.1k | |
| Independent Member of Supervisory Board | 4.5yrs | US$128.96k | 0% $ 0 |
3.5yrs
Average Tenure
56.5yo
Average Age
Experienced Board: 9VC's board of directors are considered experienced (3.5 years average tenure).